Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-03-02

Clinical Trial Update: Drug Monitoring of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

View source ↗

Summary

This document discusses drug monitoring of sorafenib in patients with advanced hepatocellular carcinoma. It provides updates on monitoring practices within this…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nexavar (Sorafenib)

Snippet

Sponsor: South West Sydney Local Health District | Conditions: Hepatocellular Cancer | Status: UNKNOWN